Michelle Kaku
Michelle Kaku
Verified email at
Cited by
Cited by
Development and validation of an interpretable deep learning framework for Alzheimer’s disease classification
S Qiu, PS Joshi, MI Miller, C Xue, X Zhou, C Karjadi, GH Chang, AS Joshi, ...
Brain 143 (6), 1920-1933, 2020
COVID‐19 in patients with myasthenia gravis
P Anand, MCC Slama, M Kaku, C Ong, AM Cervantes‐Arslanian, L Zhou, ...
Muscle & nerve 62 (2), 254-258, 2020
Newborn infants learn during sleep
WP Fifer, DL Byrd, M Kaku, IM Eigsti, JR Isler, J Grose-Fifer, AR Tarullo, ...
Proceedings of the National Academy of Sciences 107 (22), 10320-10323, 2010
Multimodal deep learning for Alzheimer’s disease dementia assessment
S Qiu, MI Miller, PS Joshi, JC Lee, C Xue, Y Ni, Y Wang, I De Anda-Duran, ...
Nature communications 13 (1), 3404, 2022
COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)
S Muppidi, JT Guptill, S Jacob, Y Li, ME Farrugia, AC Guidon, JO Tavee, ...
The Lancet Neurology 19 (12), 970-971, 2020
Impact of socio-economic factors in delayed reporting and late-stage presentation among patients with cervix cancer in a major cancer hospital in South India
M Kaku, A Mathew, B Rajan
Asian Pac J Cancer Prev 9 (4), 589-594, 2008
A clinician's approach to peripheral neuropathy
P Siao, M Kaku
Seminars in neurology 39 (05), 519-530, 2019
HIV neuropathy
M Kaku, DM Simpson
Current opinion in HIV and AIDS 9 (6), 521-526, 2014
Neuropathy associated with systemic amyloidosis
M Kaku, JL Berk
Seminars in Neurology 39 (05), 578-588, 2019
Pathways in the diagnosis and management of diabetic polyneuropathy
M Kaku, A Vinik, DM Simpson
Current Diabetes Reports 15, 1-16, 2015
Spotlight on botulinum toxin and its potential in the treatment of stroke-related spasticity
M Kaku, DM Simpson
Drug design, development and therapy, 1085-1099, 2016
A mixed-methods pilot study of mindfulness-based stress reduction for HIV-associated chronic pain
MC George, A Wongmek, M Kaku, A Nmashie, J Robinson-Papp
Behavioral Medicine 43 (2), 108-119, 2017
Toward an electrocortical biomarker of cognition for newborn infants
JR Isler, AR Tarullo, PG Grieve, E Housman, M Kaku, RI Stark, WP Fifer
Developmental science 15 (2), 260-271, 2012
Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25‐year longitudinal study
JN Gustine, A Staron, RE Szalat, LM Mendelson, T Joshi, FL Ruberg, ...
American journal of hematology 97 (9), 1189-1199, 2022
Peripheral neuropathies
AAF Sima, M Blaivas
Neuropathology: The Diagnostic Approach. Garcia J., McKeevar P., Sima AAF …, 1997
Neuromuscular complications of HIV infection
M Kaku, DM Simpson
Handbook of Clinical Neurology 152, 201-212, 2018
Neurological manifestations of hereditary transthyretin amyloidosis: a focus on diagnostic delays
MC Kaku, S Bhadola, JL Berk, V Sanchorawala, LH Connors, KHV Lau
Amyloid 29 (3), 184-189, 2022
HIV, antiretrovirals, and peripheral neuropathy: A moving target.
M Kaku, DM Simpson
Muscle & Nerve 57 (3), 347-349, 2017
Droxidopa for treatment of refractory orthostatic hypotension in patients with AL amyloidosis: A case series
JNR Lopez, LM Mendelson, T Joshi, D Hughes, MC Kaku, ...
Blood 138, 4737, 2021
Neuralgic amyotrophy following high-dose melphalan and autologous peripheral blood stem cell transplantation for AL amyloidosis
VP Nguyen, D Brauneis, M Kaku, JM Sloan, S Sarosiek, K Quillen, ...
Bone Marrow Transplantation 53 (3), 371-373, 2018
The system can't perform the operation now. Try again later.
Articles 1–20